Document Detail


Recurrent hypoglycemia increases hypothalamic glucose phosphorylation activity in rats.
MedLine Citation:
PMID:  20667558     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The mechanisms underpinning impaired defensive counterregulatory responses to hypoglycemia that develop in some people with diabetes who suffer recurrent episodes of hypoglycemia are unknown. Previous work examining whether this is a consequence of increased glucose delivery to the hypothalamus, postulated to be the major hypoglycemia-sensing region, has been inconclusive. Here, we hypothesized instead that increased hypothalamic glucose phosphorylation, the first committed intracellular step in glucose metabolism, might develop following exposure to hypoglycemia. We anticipated that this adaptation might tend to preserve glucose flux during hypoglycemia, thus reducing detection of a falling glucose. We first validated a model of recurrent hypoglycemia in chronically catheterized (right jugular vein) rats receiving daily injections of insulin. We confirmed that this model of recurrent insulin-induced hypoglycemia results in impaired counterregulation, with responses of the key counterregulatory hormone, epinephrine, being suppressed significantly and progressively from the first day to the fourth day of insulin-induced hypoglycemia. In another cohort, we investigated the changes in brain glucose phosphorylation activity over 4 days of recurrent insulin-induced hypoglycemia. In keeping with our hypothesis, we found that recurrent hypoglycemia markedly and significantly increased hypothalamic glucose phosphorylation activity in a day-dependent fashion, with day 4 values 2.8 ± 0.6-fold higher than day 1 (P < .05), whereas there was no change in glucose phosphorylation activity in brain stem and frontal cortex. These findings suggest that the hypothalamus may adapt to recurrent hypoglycemia by increasing glucose phosphorylation; and we speculate that this metabolic adaptation may contribute, at least partly, to hypoglycemia-induced counterregulatory failure.
Authors:
Mayowa A Osundiji; Paul Hurst; Stephen P Moore; S Pauliina Markkula; Chen Y Yueh; Ashwini Swamy; Shu Hoashi; Jill S Shaw; Christine H Riches; Lora K Heisler; Mark L Evans
Related Documents :
9096968 - Severe hypoglycemia in children with iddm. a prospective population study, 1992-1994.
7002978 - Alternation in both insulin release and its hypoglycemic effects in atopic bronchial as...
8334578 - Paroxysmal dyskinesia associated with hypoglycemia.
12765948 - Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 d...
16356228 - Intensive insulin therapy does not alter the inflammatory response in patients undergoi...
11252688 - Effects of sulfasalazine treatment on serum immunoglobulin levels in children with juve...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-07-29
Journal Detail:
Title:  Metabolism: clinical and experimental     Volume:  60     ISSN:  1532-8600     ISO Abbreviation:  Metab. Clin. Exp.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-22     Completed Date:  2011-05-23     Revised Date:  2011-07-27    
Medline Journal Info:
Nlm Unique ID:  0375267     Medline TA:  Metabolism     Country:  United States    
Other Details:
Languages:  eng     Pagination:  550-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Department of Medicine and Institute of Metabolic Science, University of Cambridge, Addenbrookes Hospital, Cambridge, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Glucose / metabolism
Brain Chemistry / physiology
Disease Models, Animal
Epinephrine / blood
Glucagon / blood
Glucose / metabolism*
Hypoglycemia / metabolism*
Hypothalamus / metabolism*
Male
Phosphorylation
Rats
Rats, Sprague-Dawley
Recurrence
Grant Support
ID/Acronym/Agency:
081713//Wellcome Trust; R01DK065171/DK/NIDDK NIH HHS; //Wellcome Trust
Chemical
Reg. No./Substance:
0/Blood Glucose; 50-99-7/Glucose; 51-43-4/Epinephrine; 9007-92-5/Glucagon
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  [Natriuretic peptides: new indications?].
Next Document:  Association of calpain 10 gene polymorphisms with type 2 diabetes mellitus in Southern Indians.